BPM’s Julie West, Michael VanderKlugt and Robert Houston share advice on reverse mergers in Life Science Leader magazine

July 10, 2023


In an era of market volatility and high inflation, companies in the life science industry are finding it harder to raise capital. For these companies, strategic planning and creative thinking are essential to secure consistent funding.

BPM’s Julie West, Michael VanderKlugt and Robert Houston explore the use of traditional reverse mergers as an option for life science startups. They argue that reverse mergers not only provide an efficient way to raise capital and enhance visibility but also offer an economical route to going public. They also underline the importance of due diligence, regulatory compliance and an understanding of the tax implications for any company considering this route.

Read the full article, “What Life Sciences Startups Can Do About Market Swings,” on Life Science Leader’s website. Please note that a subscription may be required to access the content.

Profile picture of Bob Houston

Bob Houston

Of Counsel, Tax
M&A Leader

Bob’s practice includes Merger & Acquisition transaction services and tax structuring for multinational multi-entity organizations, including extensive experience with public …

Profile picture of Michael VanderKlugt

Michael VanderKlugt

Partner, Assurance
Life Science Co-leader

Michael is a Partner in Assurance at BPM. He has 30 years of public accounting experience, primarily with a Big …

Profile picture of Julie West

Julie West

Partner, Tax
Tax Practice Group Leader
BPM Board of Directors
Life Science Co-leader

Julie West heads BPM’s Tax Practice and co-leads the Life Science Industry Group. She has served on BPM’s Board of Directors …